• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR

NYRADA INC.

4.76% ! 11.0¢
Market Cap $23.13M  !

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NYR 21/03/25 114 20K
21/03/25 Last post  zecs Comments Created with Sketch.  114  Views Created with Sketch.  20K 
NYR 21/03/25 24 2.6K
21/03/25 Last post  manishv Comments Created with Sketch.  24  Views Created with Sketch.  2.6K 
NYR
CHART
20/03/25 1 599
20/03/25 Last post  riftb Comments Created with Sketch.  1  Views Created with Sketch.  599 
NYR 12/03/25 0 256
12/03/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  256 
NYR 18/02/25 0 306
18/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  306 
NYR 12/02/25 77 16K
12/02/25 Last post  Dje Comments Created with Sketch.  77  Views Created with Sketch.  16K 
NYR 07/02/25 10 2.9K
07/02/25 Last post  TradingHault Comments Created with Sketch.  10  Views Created with Sketch.  2.9K 
NYR 23/01/25 224 53K
23/01/25 Last post  Bendunstan Comments Created with Sketch.  224  Views Created with Sketch.  53K 

See All Discussions arrow Created with Sketch.

Timeline

Nyrada Commences Phase I Clinical Trial Recruitment
17 Mar 09:19
 
2025 EGM Letter to Shareholders, Notice of Meeting and Proxy
12 Mar 08:25
 
Nyrada Half Year Results FY2025
18 Feb 14:15
 
Appendix 4D and Half Year Report to 31 December 2024
18 Feb 14:11
 
Nyrada to Commence Phase Ia Clinical Trial
07 Feb 11:49
 
Quarterly Activities Report and Appendix 4C
23 Jan 11:23
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
11.0¢
Change
0.005(4.76%)
Mkt cap ! $23.13M
Open High Low Value Volume
11.0¢ 11.0¢ 10.0¢ $150.3K 1.387M

Buyers (Bids)

No. Vol. Price($)
1 20181 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 268927 6
View Market Depth
Last trade - 16.10pm 21/03/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.